Results 221 to 230 of about 914,564 (294)

Feasibility and Acceptability of a Community and Family-Based Fitness and Healthy Lifestyle Program Among Latino Families: The Athletes for Life Program. [PDF]

Am J Lifestyle Med
Vargas Tequida B, Vega-López S, Flórez-Pregonero A, Todd M, Ray F, Shaibi GQ, Crespo NC.   +6 more
europepmc   +1 more source

Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers

British Journal of Clinical Pharmacology, EarlyView.
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić, Marta Kučan Štiglić, Ana Jelaković, Bojan Jelaković, Dinko Vitezić   +4 more
wiley   +1 more source

A machine learning-derived polygenic risk score reveals that healthy lifestyle counteracts obesity-related mortality. [PDF]

NPJ Digit Med
Xiao L, Liang S, Zeng L, Cai S, Wang J, Hong C, Li Y, Li R, Jiang P, Xie Z, Li T, Wu S, Liu L, Wu G, Lai W.   +14 more
europepmc   +1 more source

Nonadherence and uncontrolled arterial hypertension in Croatia—Insights from the May Measurement Month 2023 campaign and Hunting the silent killer programme

British Journal of Clinical Pharmacology, EarlyView.
Aims To determine the prevalence of non‐adherence to antihypertensive medicines and to identify demographic and behavioral factors associated with non‐adherence in subjects enrolled in the May Measurement Month (MMM) 2023, as part of the permanent public health action Hunting the silent killer.
Valerija Bralić Lang, Ana Soldo, Olgica Velkovski Škopić, Sunčana Vlah Tomičević, Tin Šaban, Andrej Belančić, Ana Jelaković, Josipa Josipović, Mihaela Marinović Glavić, Ivan Pećin, Luka Prgomet, Tajana Željković Vrkić, Bojan Jelaković   +12 more
wiley   +1 more source

mHealth-based Healthy Lifestyle Promotion (MYLIFE) for metabolic syndrome risk reduction in Chinese employed adults: protocol for a cluster-randomised controlled trial. [PDF]

BMJ Open
Yu B, Tang Q, Hu Y, Zuo H, Yang B, Pan J, Jia P, Reinhardt J, Yang S.   +8 more
europepmc   +1 more source

Editorial: Healthy Lifestyles

Journal of Health and Translational Medicine, 2007
openaire   +2 more sources

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

Nutritional literacy and its influence on healthy lifestyle behavior and willingness to consume healthy food brands. [PDF]

Front Nutr
García-Salirrosas EE, Escobar-Farfán M, Veas-González I, Gomez-Bayona L, Esponda-Perez JA, Ezcurra-Zavaleta G, Urraca-Vergara EM.   +6 more
europepmc   +1 more source

Clinical pharmacology and prescribing education: An updated medical school curriculum from the British Pharmacological Society

British Journal of Clinical Pharmacology, EarlyView.
Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale, Clare Guilding, Jennifer Koenig, Michael Okorie, Reecha Sofat, Simon Maxwell   +5 more
wiley   +1 more source